Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

被引：0
作者：
Mateos, Antonio Vega [1 ]
Alfaro, Hector Alejandro Vaquera [1 ]
Vasquez, Ana Cristina Tejada [1 ]
Lopez-Garcia, Yadith Karina [1 ]
Garcia-Salas, Gerardo [1 ]
Cantu, Olga [1 ]
Gomez-De Leon, Andres [1 ]
Gomez-Almaguer, David [1 ]
Tarin-Arzaga, Luz [1 ]
Gutierrez-Aguirre, Cesar Homero [1 ]
Colunga-Pedraza, Perla R. [1 ]
机构：
[1] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Hematol, Monterrey, Mexico
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-208831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1665 / 1666
页数：2
相关论文
共 50 条
  • [31] Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
    Orellana-Noia, Victor M.
    Isaac, Krista
    Wages, Nolan A.
    Malecek, Mary-Kate
    Bartlett, Nancy L.
    Voorhees, Timothy J.
    Grover, Natalie S.
    Hwang, Steven R.
    Bennani, N. Nora
    Hu, Rachel
    Hill, Brian T.
    Mou, Eric
    Advani, Ranjana H.
    Carter, Jordan
    David, Kevin A.
    Ballard, Hatcher J.
    Svoboda, Jakub
    Magarelli, Gabriela
    Feldman, Tatyana A.
    Churnetski, Michael C.
    Cohen, Jonathon B.
    Evens, Andrew M.
    Portell, Craig A.
    BLOOD, 2019, 134
  • [32] Initial results of the multicenter phase II trial of a novel hypofractionated low-dose radiotherapy for indolent non-Hodgkin lymphoma
    Wang, X-Y.
    Gao, L-R.
    Wang, L.
    Zhang, X.
    Chen, K.
    Feng, X.
    Zheng, R.
    Li, Y-X.
    Qi, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S601 - S601
  • [33] Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG Nivahl Trial
    Broeckelmann, Paul J.
    Buehnen, Ina
    Herhaus, Peter
    Meissner, Julia
    Trautmann-Grill, Karolin
    Mueller, Horst
    Fuchs, Michael
    von Tresckow, Bastian
    Borchmann, Peter
    Engert, Andreas
    Behringer, Karolin
    BLOOD, 2023, 142
  • [34] Radiation dose in non-Hodgkin's lymphoma: Preliminary results of UKNCRN randomised trial
    Hoskin, P
    ANNALS OF ONCOLOGY, 2005, 16 : 51 - 51
  • [35] Low-dose gemcitabine plus cisplatin in previously treated, relapsed non-Hodgkin's lymphoma
    Wong, SF
    Lindgren, T
    Hsu, D
    Tran, G
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (04) : 298 - 298
  • [36] Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG NIVAHL Trial
    Broeckelmann, Paul J.
    Buehnen, Ina
    Herhaus, Peter
    Meissner, Julia
    Trautmann, Karolin
    Mueller, Horst
    Fuchs, Michael
    von Tresckow, Bastian
    Borchmann, Peter
    Engert, Andreas
    Behringer, Karolin
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 115 - 115
  • [37] Low-dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource-constrained setting
    Chan, Thomas S. Y.
    Hwang, Yu-Yan
    Khong, Pek-Lan
    Leung, Anskar Y. H.
    Chim, Chor-Sang
    Tse, Eric W. C.
    Kwong, Yok-Lam
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (05) : 726 - 736
  • [38] A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: Long-term results
    Khaled, HM
    Zekri, ZK
    Mokhtar, N
    Ali, NM
    Darwish, T
    Elattar, I
    Gaafar, R
    Moawad, MS
    ANNALS OF ONCOLOGY, 1999, 10 (12) : 1489 - 1492
  • [39] Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
    Moskowitz, Alison J.
    Shah, Gunjan
    Schoeder, Heiko
    Ganesan, Nivetha
    Drill, Esther
    Hancock, Helen
    Davey, Theresa
    Perez, Leslie
    Ryu, Sunyoung
    Sohail, Samia
    Santarosa, Alayna
    Galasso, Natasha
    Neuman, Rachel
    Liotta, Brielle
    Blouin, William
    Kumar, Anita
    Lahoud, Oscar
    Batlevi, Connie L.
    Hamlin, Paul
    Straus, David J.
    Rodriguez-Rivera, Ildefonso
    Owens, Colette
    Caron, Philip
    Intlekofer, Andrew M.
    Hamilton, Audrey
    Horwitz, Steven M.
    Falchi, Lorenzo
    Joffe, Erel
    Johnson, William
    Lee, Christina
    Palomba, M. Lia
    Noy, Ariela
    Matasar, Matthew J.
    Pongas, Georgios
    Salles, Gilles
    Vardhana, Santosha
    Sanin, Beatriz Wills
    von Keudell, Gottfried
    Yahalom, Joachim
    Dogan, Ahmet
    Zelenetz, Andrew D.
    Moskowitz, Craig H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28) : 3109 - +
  • [40] Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results
    Michalaki, Vasiliki
    Gennatas, Spyridon
    Gennatas, Konstantine
    ANTI-CANCER DRUGS, 2009, 20 (03) : 204 - 207
12345